Mustang Bio, Inc. (MBIO): Operating Income
-$2.43M
Year ended 2025-12-31
-$3.52M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$2.43M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$16.25M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$49.26M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$76.16M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$66.72M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$56.81M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$45.88M | n/m | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | -$31.22M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$31.79M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$11.36M | n/a | 2018-03-29, From 2016-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | -$2.43M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$18.21M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$4.28M | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$23.08M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$10.37M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$12.61M | n/m |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$26.57M | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$19.57M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$33.21M | n/m |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗